Your shopping cart is currently empty

Apoptosisinducer 17 is a hybrid molecule of Curcumin-Piperlongumine that enhances cell cycle arrest and apoptosis (apoptosis) in lung cancer cells by activating the JNK signaling pathway.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Apoptosisinducer 17 is a hybrid molecule of Curcumin-Piperlongumine that enhances cell cycle arrest and apoptosis (apoptosis) in lung cancer cells by activating the JNK signaling pathway. |
| In vitro | Apoptosis inducer 17 (compound CP; 0.027-60 μM; 72 h) effectively inhibits cell proliferation with IC50 values of 0.021 μM, 0.027 μM, and 0.73 μM for H446, H1299, and SBC-2 cells, respectively. It demonstrates significant colony formation inhibition at 0.03-0.3 μM over 24 hours. JNK-IN-17 induces dose-dependent G2/M phase arrest in H446 and H1299 cells. Additionally, Apoptosis inducer 17 (compound CP; 0.03-0.3 μM; 24 hours) promotes apoptosis in H446 and H1299 cells mediated by caspase activity and activates the JNK signaling cascade. |
| In vivo | Compound CP, administered at 10 mg/kg via intraperitoneal injection twice daily for 15 days, significantly reduced H446 cell growth without causing notable changes in body weight. |
| Formula | C25H27NO7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.